Trial Identifiers
Use the hyperlinks, where available to access additional clinical trial information.
Trial sponsor
Synthorx, Inc.
Scientific Title
An Open-Label, Multicenter Phase 1/2 Dose Escalation and Expansion Study of THOR-707 as a Single Agent and in Combination With a Checkpoint Inhibitor in Adult Subjects With Advanced or Metastatic Solid Tumors